American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, announced today that it will hold a conference call to discuss its first quarter 2026 financial results on May 14, 2026, at 12:00 PM ET. The financial results press release will be issued before the market opens on the same day.
The call will provide investors and analysts with an opportunity to hear from management about the company's performance and outlook. Participants can dial 1-844-413-3972 (domestic) or 1-412-317-5776 (international) at least 10 minutes prior to the start time. A simultaneous webcast will be available on the company's website at www.ashs.com or directly via the link https://event.choruscall.com/mediaframe/webcast.html?webcastid=NAuZg0I8A.
A replay of the call will be available from May 14 through May 21, 2026, by dialing 1-855-669-9658 or 1-412-317-0088, access code 6753554. The replay will also be accessible on the company's website.
American Shared Hospital Services provides turnkey solutions to cancer treatment centers, health systems, and cancer networks in North and South America. The company works with partners to develop and grow their cancer service lines, offering integrated cancer care in local settings. Under health system partnerships, the company and its partners share capital investment costs and profitability based on respective ownership interests.
The announcement comes as the company continues to expand its Gamma Knife, proton therapy, and advanced radiation therapy services. Forward-looking statements in the press release involve risks and uncertainties, including economic conditions, compliance with debt covenants, variability in financial results, changes in CMS reimbursement rates, and risks associated with business expansion and acquisitions. Further details are available in the company's filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2025.